Artivion, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US2289031005
USD
45.41
-0.07 (-0.15%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Artivion, Inc. stock-summary
stock-summary
Artivion, Inc.
Pharmaceuticals & Biotechnology
CryoLife, Inc. (CryoLife) is a medical device manufacturer and processor, and is engaged in the distribution of medical devices and implantable human tissues used in cardiac surgical procedures. The Company operates through two segments: Medical Devices and Preservation Services. The Medical Devices segment includes medical devices, such as Surgical Sealants, BioGlue products, JOTEC products, On-X products, CardioGenesis cardiac laser therapy, PerClot, PhotoFix, and NEXUS. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues.
Company Coordinates stock-summary
Company Details
1655 Roberts Blvd NW , KENNESAW GA : 30144-3632
stock-summary
Tel: 1 770 41933551 646 9241769
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 60 Schemes (49.24%)

Foreign Institutions

Held by 82 Foreign Institutions (7.33%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. James Mackin
Chairman of the Board, President, Chief Executive Officer, Director
Mr. Ronald McCall
Presiding Independent Director
Mr. Thomas Ackerman
Independent Director
Mr. Daniel Bevevino
Independent Director
Ms. Marna Borgstrom
Independent Director
Mr. James Bullock
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
113 Million
(Quarterly Results - Jun 2025)
Net Profit:
1 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 2,114 Million (Small Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.40

stock-summary
Return on Equity

-1.88%

stock-summary
Price to Book

5.04